https://orcid.org/0000-0003-0978-9573
References
- Zacchia M, Abategiovanni ML, Stratigis S, et al. Potassium: from physiology to clinical implications. Kidney Dis. 2016;2(2):72–79.
- Zhou F, Zhao B, Gu D. Evaluation of laboratory critical serum potassium values and their association with clinical symptoms in Chinese Han patients. J Int Med Res. 2015;43(6):851–861.
- Berardi R, Torniai M, Lenci E, et al. Electrolyte disorders in cancer patients: a systematic review. J Cancer Metastasis Treat. 2019;5:79.
- Bnaya A, Ruchlemer R, Itzkowitz E, et al. Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia. Int J Hematol. 2021;114(1):102–108.
- Polak R, Huisman A, Sikma MA, et al. Spurious hypokalaemia and hypophosphataemia due to extreme hyperleukocytosis in a patient with a haematological malignancy. Ann Clin Biochem. 2010;47(Pt 2):179–181.
- Kintzel PE, Scott WL. Pseudohyperkalemia in a patient with chronic lymphoblastic leukemia and tumor lysis syndrome. J Oncol Pharm Pract. 2012;18(4):432–435.
- Su YJ, Huang CC, Hsieh CY, et al. Hyperkalemia in a patient with leukemia. Am J Kidney Dis. 2021;77(5):A13–A14.
- Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
- Casati M, Intra J, Rossi W, et al. Hemolysis and blood gas analysis: it’s time for a change! Scand. J Clin Lab Invest. 2022;82(2):138–142.
- Cooper LB, Savarese G, Carrero JJ, et al. Clinical and research implications of serum versus plasma potassium measurements. Eur J Heart Fail. 2019;21(4):536–537.